NSEAnalysts/Institutional Investor Meet/Con. Call Updates11 Sept 2026 · 11 Sept 2026, 04:05 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Global Health Limited · MEDANTA

✦ AI SummaryMgmt Change

Global Health Limited has informed the Exchange about the schedule of analysts/institutional investor meetings to be held on September 17 and 18, 2026, in Gurugram and Mumbai respectively, where the company's management will meet investors and analysts.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Global Health Limited has informed the Exchange about Schedule of meet.

Attachments (1)

📄

MEDANTA21_11092026160351_GHLANALYSTSMEETSEPTEMBER112026Signed.pdf

pdf

Download →
View document text
Date: September 11, 2026 Ref:- GHL/2026-27/EXCH/53 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Schedule of Analysts/Institutionals Investor Meeting Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will meet Investors/Analysts in Meetings organised as per the below schedule: Organized by Date of Meeting Type of Meeting Place of Mode of Meeting Meeting Jefferies India September 17 , 2026 Group Gurugram In Person Forum 2026 Kotak Healthcare September 18 , 2026 Group Mumbai In Person Forum 2026 Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on the part of Analysts/Investors/Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319